Tevogen Bio Inc. (TVGN)
Tevogen Bio Statistics
Share Statistics
Tevogen Bio has 183.89M shares outstanding. The number of shares has increased by 4.75% in one year.
| Shares Outstanding | 183.89M |
| Shares Change (YoY) | 4.75% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 1.36% |
| Shares Floating | 26.87M |
| Failed to Deliver (FTD) Shares | 6.43K |
| FTD / Avg. Volume | 0.38% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -11.01 and the forward PE ratio is null. Tevogen Bio's PEG ratio is 0.
| PE Ratio | -11.01 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | -22.64 |
| P/FCF Ratio | -12.59 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tevogen Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.26, with a Debt / Equity ratio of -0.28.
| Current Ratio | 0.26 |
| Quick Ratio | 0.26 |
| Debt / Equity | -0.28 |
| Debt / EBITDA | -0.04 |
| Debt / FCF | -0.16 |
| Interest Coverage | 291.05 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-762.63K |
| Employee Count | 18 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -1% in the last 52 weeks. The beta is -0.82, so Tevogen Bio's price volatility has been lower than the market average.
| Beta | -0.82 |
| 52-Week Price Change | -1% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.07 |
| Relative Strength Index (RSI) | 43.7 |
| Average Volume (20 Days) | 1.7M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -53.56M |
| Net Income | -13.73M |
| EBITDA | -53.56M |
| EBIT | -13.91M |
| Earnings Per Share (EPS) | -0.09 |
Balance Sheet
The company has 1.28M in cash and 1.89M in debt, giving a net cash position of -602.86K.
| Cash & Cash Equivalents | 1.28M |
| Total Debt | 1.89M |
| Net Cash | -602.86K |
| Retained Earnings | -113.39M |
| Total Assets | 3.46M |
| Working Capital | -6.68M |
Cash Flow
In the last 12 months, operating cash flow was -12M and capital expenditures 0, giving a free cash flow of -12M.
| Operating Cash Flow | -12M |
| Capital Expenditures | 0 |
| Free Cash Flow | -12M |
| FCF Per Share | -0.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TVGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for TVGN is $10, which is 910.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 910.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | -49.02 |
| Piotroski F-Score | 5 |